Get Connected:

Top Medical News Today

FDA Approves New Treatment for Schizophrenia
Aristada (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia features once-monthly and six-week dosing options.
California's Gov. Jerry Brown signed a controversial law permitting physicians to prescribe lethal doses of drugs in cases where a patient has six months or less to live.
The US Food and Drug Administration today approved combining ambrisentan (Letairis/Gilead) with tadalafil to treat pulmonary arterial hypertension.
The hallmark degenerative process in spinal cord injury may be caused by lysophosphatidic acid, the lipid that acts as a signal between various cells, according to findings published in The Journal of Neuroscience.
The FDA approved a new bioabsorbable polymer drug-eluting stent system for coronary artery disease.
There is a positive association of measures of pulmonary function with lipoprotein a [Lp(a)] in older adults who live in a community setting, according to a recent study.
Incidences of inflammatory bowel disease (IBD) have grown in patients also suffering from autism spectrum disorders (ASD), a neurocognitive disorder characterized by an impaired ability to communicate and interact.
The “obesity paradox” suggests that patients with excess weight are associated with better survival among individuals with cardiovascular disease —a mysterious and confounding phenomenon that has been demonstrated in many clinical studies.
Researchers have found that current smokers and those with chronic bronchitis are likely to have greater goblet cell density (GCD) than non-smokers or people with chronic obstructive pulmonary disease (COPD)


$vacMongoViewPlus$ $vAR$